Clinical Trials
4 trialsNCT04142437 2026-04-14
ON-TRK
Bayer
Recruiting
NCT04945330 2026-04-14
NTRK Gene Fusion - Positive Advanced or Recurrent Solid Tumors, a Rare Cancer Caused by Specific Changes in the Genes
Bayer
Recruiting
NCT05236257 2024-12-10
EPI VITRAKVI
Bayer
Completed
NCT05192642 2023-11-14
A Study Called VICTORIA to Learn More About How Well Larotrectinib Works in Adults With TRK Fusion-positive Cancer by Comparing Larotrectinib Data From Clinical Studies With Data of Other Treatments From Actual Practice
Bayer
Completed